Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Study: Sex matters when it comes to susceptibility to infections and other health conditions

Study: Sex matters when it comes to susceptibility to infections and other health conditions

Miniature CRISPR-Cas system expands applicability and implications further

Miniature CRISPR-Cas system expands applicability and implications further

Researchers develop method to preserve high-quality cultured stem cells for a long time

Researchers develop method to preserve high-quality cultured stem cells for a long time

Researchers identify gene responsible for vicine-convicine content in faba beans

Researchers identify gene responsible for vicine-convicine content in faba beans

Study identifies the gene responsible for toxic vicine and convicine production in faba beans

Study identifies the gene responsible for toxic vicine and convicine production in faba beans

Study shows that declining fish biodiversity can affect human nutrition

Study shows that declining fish biodiversity can affect human nutrition

Study unravels a crucial element that influences gene expression in blood stem cells

Study unravels a crucial element that influences gene expression in blood stem cells

New gene editing approach bypasses disease-causing mutations

New gene editing approach bypasses disease-causing mutations

New gene editor could help treat genetic disorders caused by single-nucleotide mutations

New gene editor could help treat genetic disorders caused by single-nucleotide mutations

Study identifies molecular mechanism by which HSPCs recover after chemotherapy-induced injury

Study identifies molecular mechanism by which HSPCs recover after chemotherapy-induced injury

Study explores factors that influence the disparities in sickle cell disease

Study explores factors that influence the disparities in sickle cell disease

Microfluidic chip and AI-based microscope help measure hemoglobin levels

Microfluidic chip and AI-based microscope help measure hemoglobin levels

Study shows TALEN is five times more efficient than CRISPR-Cas9 tool

Study shows TALEN is five times more efficient than CRISPR-Cas9 tool

Study: CAR T cell therapy is a safe, effective therapy for high-risk large B-cell lymphoma

Study: CAR T cell therapy is a safe, effective therapy for high-risk large B-cell lymphoma

Subcutaneous injection of teclistamab drug shows promise in treating aggressive multiple myeloma

Subcutaneous injection of teclistamab drug shows promise in treating aggressive multiple myeloma

Scientists use new technology to observe DNA defects in children with Fanconi anemia

Scientists use new technology to observe DNA defects in children with Fanconi anemia

Somatic mutation acts as natural gene therapy in patients with GATA2 deficiency

Somatic mutation acts as natural gene therapy in patients with GATA2 deficiency

Study probes mechanism by which COVID-19 distribution in the body damages erythrocytes

Study probes mechanism by which COVID-19 distribution in the body damages erythrocytes

Plant genetic engineering can help address micronutrient malnutrition

Plant genetic engineering can help address micronutrient malnutrition

Developing a 'Trojan Horse' nanotherapy to fight breast cancer

Developing a 'Trojan Horse' nanotherapy to fight breast cancer